World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
124
Citations
109015
World Ranking
3143
National Ranking
1737

James D. Neaton publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where James D. Neaton sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 416 publications — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

James D. Neaton D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where James D. Neaton sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 124 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 1994 - Fellow of the American Statistical Association (ASA)

Overview

James D. Neaton is affiliated with the University of Minnesota in the United States. Their research primarily focuses on Medicine, with a notable emphasis on Infectious Diseases, Virology, and Epidemiology, as well as contributions to Neurology and Molecular Biology. The scientist's work encompasses a broad range of topics related to viral infections and treatments.

Neaton has published extensively on subjects including COVID-19 Clinical Research Studies, HIV Research and Treatment, and Viral Infections and Outbreaks Research. The following main topics have been a consistent part of their research portfolio:

  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • HIV Research and Treatment
  • Viral Infections and Outbreaks Research
  • Long-Term Effects of COVID-19
  • HIV/AIDS drug development and treatment
  • Viral Infections and Vectors

The scientist's recent published papers include:

  • Remdesivir for the Treatment of Covid-19 - Final Report, 2020, New England Journal of Medicine
  • A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19, 2020, New England Journal of Medicine
  • Randomized Trial of Vaccines for Zaire Ebola Virus Disease, 2022, New England Journal of Medicine
  • The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19, 2022, Annals of Internal Medicine
  • Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3), 2021, Clinical Trials

Frequent co-authors collaborating with James D. Neaton include:

  • H. Clifford Lane
  • Jens Lundgren
  • Virginia L. Kan
  • Elizabeth S. Higgs
  • Abdel G. Babiker

Neaton's work has been published predominantly in several scientific journals. The main publication venues are:

  • New England Journal of Medicine
  • AIDS
  • JCI Insight
  • PLoS ONE
  • Trials

In 1994, James D. Neaton was recognized as a Fellow of the American Statistical Association (ASA).

Best Publications

  • Remdesivir for the Treatment of Covid-19 - Final Report.

    John H. Beigel;Kay M. Tomashek;Lori E. Dodd;Aneesh K. Mehta

  • Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.

    Jeremiah Stamler;Olga Vaccaro;James D. Neaton;Deborah Wentworth

  • Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

    Bertram Pitt;Willem Remme;Faiez Zannad;James Neaton

  • Blood pressure, stroke, and coronary heart disease: Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

    S Macmahon;R Peto;J E Cutler;R Collins

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

    D. J. Gordon;J. L. Probstfield;R. J. Garrison;Jim Neaton

  • Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

    Jeremiah Stamler;Deborah Wentworth;James D. Neaton

  • CD4+ count-guided interruption of antiretroviral treatment.

    Wafaa El-Sadr;Wafaa El-Sadr;Jens D Lundgren;James Neaton;Fred Gordin

  • Initiation of antiretroviral therapy in early asymptomatic HIV infection

    Sean Emery;Shweta Sharma;Gerd Fätkenheuer;Josep M. Llibre

  • Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II

    Bertram Pitt;Philip A Poole-Wilson;Robert Segal;Felipe A Martinez

  • Blood Pressure and End-Stage Renal Disease in Men

    Michael J. Klag;Paul K. Whelton;Bryan L. Randall;James D. Neaton

  • Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

    Lewis H Kuller;Russell Tracy;Waldo Belloso;Stephane De Wit

  • Blood Pressure, Systolic and Diastolic, and Cardiovascular Risks: US Population Data

    Jeremiah Stamler;Rose Stamler;James D. Neaton

  • The Prevention and Treatment of Missing Data in Clinical Trials

    Roderick J. Little;Ralph D'Agostino;Michael L. Cohen;Kay Dickersin

  • Treatment of Mild Hypertension Study: Final Results

    J D Neaton;R H Grimm;R J Prineas;J Stamler

  • Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial

    Hiroyasu Iso;David R. Jacobs;Deborah Wentworth;James D. Neaton

  • Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events

    Philip Greenland;Maria Deloria Knoll;Jeremiah Stamler;James D. Neaton

  • Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection

    Netanya Sandler;Handan Wand;Annelys Roque;Matthew G Law

  • Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality.: A collaborative meta-analysis of high-risk population cohorts

    Marije van der Velde;Kunihiro Matsushita;Josef Coresh;Brad C. Astor

  • Blood pressure, systolic and diastolic, and cardiovascular risks

    Jeremiah Stamler;Rose Stamler;Jim Neaton

Frequent Co-Authors

Jeremiah Stamler
Jeremiah Stamler Northwestern University
Jens D. Lundgren
Jens D. Lundgren Rigshospitalet
Richard H. Grimm
Richard H. Grimm University of Minnesota
Lewis H. Kuller
Lewis H. Kuller University of Pittsburgh
H. Clifford Lane
H. Clifford Lane National Institute of Allergy and Infectious Diseases
Ronald J. Prineas
Ronald J. Prineas Wake Forest University
Sean Emery
Sean Emery University of New South Wales
Andrew N. Phillips
Andrew N. Phillips University College London
Donald I. Abrams
Donald I. Abrams University of California, San Francisco
David R. Jacobs
David R. Jacobs University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in expanding their medical career options, a growing number of flexible online degrees can help you enter or advance within healthcare fields. Beyond traditional medicine, there is strong demand for professionals with leadership and management skills. Earning health administration degrees online can open doors to roles in hospital administration, patient services, and healthcare operations.

For those seeking higher-level opportunities, many universities now offer online mha programs affordable enough for working professionals. These programs provide advanced training in policy, finance, and healthcare leadership. Similarly, nurses can elevate their practice and earning potential by pursuing the cheapest dnp online programs, earning a Doctor of Nursing Practice without relocating or pausing their careers.

Pharmacists aiming to accelerate their education can now consider a 3 year online pharmd to obtain a Doctor of Pharmacy degree in less time. As healthcare evolves, these online pathway programs offer both flexibility and new career options for those studying medicine in the USA.

Best Scientists Citing James D. Neaton

Trending Scientists

Recently Published Articles